Recently, we have shown that functional variability in BuChE activity, due to either genetic polymorphism or high ApoE protein, regulates the intrathecal cytokine and astroglial biomarker profile in patients with AD [35], [36]. This evidence concerns the gene APOE and Alzheimer disease.